Resmed Inc. buy Citigroup Inc.
Start price
15.06.26
/
50%
€166.40
Target price
15.06.27
€232.47
Performance (%)
18.21%
Price
22:25
€196.70
Summary
This prediction is currently active. The prediction currently has a performance of 18.21%. This prediction currently runs until 15.06.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 1.056% | 1.056% |
| iShares Core DAX® | 0,63 % | 4,95 % |
| iShares Nasdaq 100 | 1,16 % | -1,16 % |
| iShares Nikkei 225® | 2,36 % | -1,35 % |
| iShares S&P 500 | 0,63 % | 1,38 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Resmed Inc. diskutieren
ResMed (RMD) had its price target lowered by Citigroup Inc. to $270.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat